1. Evaluating the impact of regulatory action on denosumab‐induced hypocalcaemia in Japan. (7th July 2019) Authors: Imatoh, Takuya; Sai, Kimie; Takeyama, Mayu; Segawa, Katsunori; Yamashita, Takanori; Nakashima, Naoki; Kataoka, Yoko; Yokoi, Hideto; Hiramatsu, Tatsuo; Ohe, Kazuhiko; Kimura, Michio; Hori, Katsuhito; Kawakami, Junichi; Saito, Yoshiro Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 44:Number 5(2019) Page Start: 788 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Identification of risk factors and development of detection algorithm for denosumab‐induced hypocalcaemia. (24th August 2018) Authors: Imatoh, Takuya; Sai, Kimie; Takeyama, Mayu; Hori, Katsuhito; Karayama, Masato; Furuhashi, Kazuki; Segawa, Katsunori; Kimura, Michio; Kawakami, Junichi; Saito, Yoshiro Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 44:Number 1(2019) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗